MIMI I-NAN HU to Molecular Targeted Therapy
This is a "connection" page, showing publications MIMI I-NAN HU has written about Molecular Targeted Therapy.
Connection Strength
0.079
-
Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab. 2014 Jun; 99(6):2086-94.
Score: 0.058
-
Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. 2019 Aug; 145(8):1977-1986.
Score: 0.021